Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.

A. M. Eggermont; H. Schraffordt Koops; J. M. Klausner; P. M. Schlag; B. B. Kroon; G. Ben-Ari; F. J. Lejeune

doi:10.1007/978-1-4615-6121-7_13

Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.

A. M. Eggermont, H. Schraffordt Koops, J. M. Klausner, P. M. Schlag, B. B. Kroon, G. Ben-Ari, F. J. Lejeune

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

21 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	189-203
Aantal pagina's	15
Tijdschrift	Cancer treatment and research
Volume	91
DOI's	https://doi.org/10.1007/978-1-4615-6121-7_13
Status	Gepubliceerd - 1997
Extern gepubliceerd	Ja

Toegang tot document

10.1007/978-1-4615-6121-7_13

Citeer dit

@article{f16b8f304d8e4ab183fbf520da4e4005,

title = "Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.",

author = "Eggermont, \{A. M.\} and \{Schraffordt Koops\}, H. and Klausner, \{J. M.\} and Schlag, \{P. M.\} and Kroon, \{B. B.\} and G. Ben-Ari and Lejeune, \{F. J.\}",

year = "1997",

doi = "10.1007/978-1-4615-6121-7\_13",

language = "English",

volume = "91",

pages = "189--203",

journal = "Cancer treatment and research",

issn = "0927-3042",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas.

AU - Eggermont, A. M.

AU - Schraffordt Koops, H.

AU - Klausner, J. M.

AU - Schlag, P. M.

AU - Kroon, B. B.

AU - Ben-Ari, G.

AU - Lejeune, F. J.

PY - 1997

Y1 - 1997

UR - https://www.scopus.com/pages/publications/0030625628

U2 - 10.1007/978-1-4615-6121-7_13

DO - 10.1007/978-1-4615-6121-7_13

M3 - Article

C2 - 9286497

AN - SCOPUS:0030625628

SN - 0927-3042

VL - 91

SP - 189

EP - 203

JO - Cancer treatment and research

JF - Cancer treatment and research

ER -